Mental wellbeing
Depression: treatment options and their limits
On this page
Depression can involve persistent low mood or loss of interest with changes in sleep, energy, thinking, and functioning. Treatment may include psychological therapy, medication, or other specialist approaches.[1]
Episode duration, severity and accompanying features are separate distinctions
Major depression involves persistent low mood or loss of interest together with other symptoms and impaired daily life; it differs from a passing period of sadness. A history and assessment matter because biological, genetic, environmental and psychological factors can all contribute. “Depression” names a clinical pattern; it does not identify one demonstrated cause in every person.[7]
Persistent depressive disorder describes a longer-lasting depressive pattern, usually at least two years in adults. Longer duration does not mean the effect on daily life is unimportant: the NIMH statistics page describes impairment ranging from mild to serious. Duration, symptom severity and functioning should therefore be considered separately, rather than treating chronic symptoms as automatically trivial.[8]
Depressive episodes can also occur within bipolar disorder, where manic episodes change the diagnostic picture and treatment approach. Asking about periods of unusually elevated or irritable mood, energy and activity helps distinguish the history. A depression symptom score alone cannot establish that unipolar-depression trial results apply to every person with a low-mood episode.[9]
A treatment effect does not establish a single cause of depression
NIMH describes depression as involving multiple interacting influences. Biological treatments and psychological therapies do not imply competing categories of “real” versus “imaginary” illness. Evidence that a medicine helps some people is evidence about that intervention and outcome; it does not prove that all depression is caused by one chemical deficiency. Conversely, a psychological treatment’s benefit does not show that symptoms are merely a voluntary attitude.[7]
Different therapies address different needs
NIMH describes structured psychological treatments such as cognitive behavioral and interpersonal therapies, antidepressants, and specialist treatments when needed. Treatment can target thoughts, behavior, relationships, symptoms, and daily functioning. Combining approaches may be appropriate. Diagnosis also matters: a history of mania or hypomania can change the assessment and treatment plan rather than being an interchangeable form of unipolar depression.[1]
Treatment choice depends partly on severity
For a new episode of less severe adult depression, NICE recommends discussing available options and matching treatment to clinical needs and informed preference. It advises considering the least intrusive and least resource-intensive appropriate option first, including guided self-help. Antidepressants are not routinely the first treatment for this group, but can be offered when they are the person's informed preference. This is a scoped guideline recommendation, not a claim that medicine never helps or that informal encouragement is equivalent to a structured treatment. Shared decisions include benefits, harms, access, and expected outcomes.[2]
Benefits, adverse effects, and stopping are separate questions
Antidepressant classes include SSRIs, SNRIs, and older categories. Effects and interactions vary. NHS describes gastrointestinal, sleep, appetite, and sexual adverse effects; individual patterns differ. Follow-up checks response and safety. Abrupt stopping can cause withdrawal, sometimes severe or prolonged; planned reduction is individualized with the prescriber. Withdrawal and recurrent depression can resemble each other and require assessment.[4]
NIMH says antidepressants commonly take several weeks to work. People under 25 can experience increased suicidal thoughts or behavior early in treatment or after a dose change; patients of all ages need monitoring. New suicidal thoughts require prompt help, rather than waiting for an expected response.[1]
Specialist brain-stimulation options
NIMH describes electroconvulsive therapy, or ECT, for some severe or treatment-resistant illnesses and situations requiring a rapid response. It uses a controlled seizure under anesthesia and can cause confusion or memory problems. Repetitive transcranial magnetic stimulation, or rTMS, uses magnetic stimulation and generally does not require anesthesia. The procedures, treatment courses, indications, and adverse effects differ. They are not interchangeable with consumer electrical gadgets or wellness devices, and require specialist assessment. Their availability and exact protocols depend on the service and clinical circumstances.[5]
Immediate help
If there is immediate danger, use emergency services. In the US, NIMH identifies 911 or an emergency department for life-threatening situations and call/text 988 for suicidal crisis or emotional distress. Outside the US, use local emergency and crisis services.[6]
Behavioral activation is structured therapeutic work
Behavioral activation helps someone examine patterns of withdrawal and avoidance, then work toward personally meaningful activities with support. It includes understanding triggers and consequences, monitoring patterns and developing alternative responses to rumination. It is more than being told to stay busy or exercise.[11]
Mindfulness-based cognitive therapy, or MBCT, combines mindfulness practice with cognitive skills for noticing and responding to patterns associated with depressive relapse. It is a taught programme with practice and support, rather than any short meditation routine.[12]
Evidence & uncertainty
Effective options exist, but no treatment works for everyone. Severity, previous response, coexisting illness, preferences, and possible bipolar symptoms influence assessment and the care plan.[1]
Selected-source overview · Independent review pendingPublished questions
Can depression treatment include both therapy and medication?
Selected-source overview · Independent review pending. Read the evidence context.
Yes. NIMH describes psychological treatment, medication, and combinations chosen according to the condition, severity, previous response, and individual circumstances.[1]
Evidence behind this answer
- Depression
agency explanation · 2024
Selected official page text; cited sections inspected · Definition; Types; Psychotherapy; Treatment selection
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Are antidepressants always the first treatment for less severe adult depression?
Selected-source overview · Independent review pending. Read the evidence context.
No. NICE recommends considering appropriate less intrusive options first, while allowing antidepressants when they reflect informed preference. The recommendation is specific to this group.[2]
Evidence behind this answer
- Depression in adults: treatment and management, NG222 — Recommendations
clinical guideline · Date not stated
Indexed official guideline excerpts; direct full-page access blocked · Recommendations 1.3.3, 1.5.2 and 1.5.3
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does an antidepressant trial's average benefit guarantee that it will help me?
Selected-source overview · Independent review pending. Read the evidence context.
No. An average response difference does not predict every person's benefit or harms, and findings apply most directly to the populations studied.[3]
Evidence behind this answer
- Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis
published systematic review · 2018
Published review abstract only; full text and risk-of-bias tables not appraised · Abstract: eligibility; Findings; Interpretation
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Can antidepressants simply be stopped abruptly?
Selected-source overview · Independent review pending. Read the evidence context.
NHS advises a planned reduction with the prescriber because abrupt stopping can cause withdrawal. The appropriate plan depends on the person and medicine.[4]
Evidence behind this answer
- Antidepressants
agency explanation · 2025-06-12
Selected official page text; cited sections inspected · Types; Side effects; Stopping; Follow-up
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Are ECT and rTMS the same procedure?
Selected-source overview · Independent review pending. Read the evidence context.
No. ECT uses a controlled seizure under anesthesia; rTMS uses magnetic stimulation. Their indications, courses, and adverse-effect profiles differ.[5]
Evidence behind this answer
- Brain Stimulation Therapies
agency explanation · Date not stated
Selected official page text; cited sections inspected · ECT; rTMS; Indications; Risks
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
What if depression is accompanied by immediate danger or suicidal thoughts?
Selected-source overview · Independent review pending. Read the evidence context.
Immediate danger needs emergency services. In the US, NIMH identifies 911 for life-threatening situations and call/text 988 for suicidal crisis; local services differ elsewhere.[6]
Evidence behind this answer
- Help for Mental Illnesses
agency explanation · 2026-04
Selected official page sections inspected · Where can I get immediate help?
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
What are the main evidence-based options for depression besides telling someone to exercise?
Selected-source overview · Independent review pending. Read the evidence context.
Options include psychological therapies such as CBT or behavioral activation, guided self-help, antidepressants, or combinations. Severity, previous response and preferences shape adult treatment; medication is not routinely first-line for less severe depression. Care includes monitoring benefit, side effects and safety, especially when suicidal thoughts emerge.[2][4]
Evidence behind this answer
- Depression in adults: treatment and management, NG222 — Recommendations
clinical guideline · Date not stated
Indexed official guideline excerpts; direct full-page access blocked · Recommendations 1.3.3, 1.5.2 and 1.5.3 - Antidepressants
agency explanation · 2025-06-12
Selected official page text; cited sections inspected · Types; Side effects; Stopping; Follow-up
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does the fact that antidepressants do not help everybody mean they never work?
Selected-source overview · Independent review pending. Read the evidence context.
No. An acute adult-depression review found average benefit over placebo, while responses and tolerability vary. An average effect neither guarantees benefit nor means treatment never works. Side effects, interactions and withdrawal also matter; effectiveness and suitability should be reviewed rather than making blanket claims.[3][4]
Evidence behind this answer
- Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis
published systematic review · 2018
Published review abstract only; full text and risk-of-bias tables not appraised · Abstract: eligibility; Findings; Interpretation - Antidepressants
agency explanation · 2025-06-12
Selected official page text; cited sections inspected · Types; Side effects; Stopping; Follow-up
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does persistent depression automatically mean mild impact?
Selected-source overview · Independent review pending. Read the evidence context.
No. Duration and impairment are different questions; NIMH reports a range of impairment in persistent depressive disorder.[8]
Evidence behind this answer
- Persistent Depressive Disorder
agency explanation · Date not stated
Selected original page passages inspected · Definition; impairment distribution (historical survey population)
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does an antidepressant benefit prove depression has one chemical cause?
Selected-source overview · Independent review pending. Read the evidence context.
No. Treatment efficacy and disease causation are different questions. NIMH describes several interacting influences rather than one universal explanation.[7]
Evidence behind this answer
- Depression
agency explanation · Date not stated
Indexed original agency passages inspected · Original agency explanation: depressive illness and interacting causes
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does the ANTLER result mean every person must stay on antidepressants forever?
Selected-source overview · Independent review pending. Read the evidence context.
No. It concerns a selected long-term-treatment population and 52-week follow-up. Withdrawal, relapse history, adverse effects and preferences affect a monitored individual plan.[10]
Evidence behind this answer
- Maintenance or Discontinuation of Antidepressants in Primary Care
randomized trial · 2021
Original abstract inspected; no independent full-text appraisal · Abstract: enrollment; randomized maintenance/discontinuation; 52-week relapse and withdrawal
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does behavioral activation mean simply being told to keep busy?
Selected-source overview · Independent review pending. Read the evidence context.
No. The studied therapy used individualized work on avoidance, meaningful activities and rumination, delivered with training and supervision. Generic activity advice is a different intervention.[11]
Evidence behind this answer
- Cost and Outcome of Behavioural Activation versus Cognitive Behavioural Therapy for Depression (COBRA): a randomised, controlled, non-inferiority trial
Randomized active-comparator noninferiority trial · 2016
Full original retrieved after native challenge; complete summary and selected procedures/discussion/disclosures read. · Summary; therapy procedures/training/supervision; missing data and applicability; disclosures
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Preventing relapse is a different trial question from treating an acute episode
ANTLER randomized 478 UK primary-care adults who felt well enough to consider stopping long-term antidepressants. Participants had recurrent depression or at least two years of treatment. At 52 weeks, relapse occurred in 39% assigned to continue and 56% assigned to taper and stop: a 17-percentage-point difference. This supports a maintenance benefit in that population, rather than proving everyone should continue indefinitely.[10]
The discontinuation group also reported more withdrawal, depression and anxiety symptoms, and adherence differed between groups. Relapse and withdrawal can overlap; the trial cannot establish the best individual taper or perfectly predict who will remain well. A benefit of continuing treatment and a preference to avoid adverse effects can both be material to a planned, monitored decision.[10]
What an average trial result establishes
Cipriani and colleagues’ 2018 review included 522 trials and 116,477 adults. All twenty-one antidepressants were more effective than placebo for acute response. An average effect does not guarantee individual benefit. Trials focusing on bipolar or psychotic depression, treatment resistance, or serious accompanying illness were excluded. These results cannot settle long-term or excluded-population outcomes. Drug comparisons require tolerability and study limitations alongside effectiveness.[3]
The review’s primary outcomes were response rate and discontinuation for any reason. Response is not automatically remission or recovery of functioning, and discontinuation is not a complete adverse-effect assessment. Its authors rated certainty from moderate to very low; the atlas has not independently reproduced that grading.[3]
A supported therapy comparison met a defined noninferiority criterion
The 2016 COBRA trial compared behavioral activation delivered by trained, supervised junior workers with cognitive behavioral therapy (CBT) from psychological therapists in 440 UK adults with depression. It met the prespecified criterion for not being unacceptably worse than CBT on twelve-month symptom scores, called noninferiority. Acutely suicidal people were excluded. Missing outcomes, incomplete attendance, unblinded delivery and concurrent antidepressants limit interpretation. This does not show that training or supervision is unnecessary, or that the approaches are identical.[11]
Relapse prevention tested a supported programme rather than medication withdrawal alone
PREVENT randomized 424 adults with at least three previous depressive episodes, currently in full or partial remission, to MBCT with clinical support for antidepressant reduction or maintenance antidepressants. Over two years, it did not demonstrate superior relapse prevention with MBCT. It was a superiority trial: nonsignificance does not establish equivalence. Participants were willing to consider either approach; not everyone followed the assigned medication strategy.[12]
Questions still to cover
Remaining dedicated reviews: psychotherapy-by-psychotherapy comparisons; long-term relapse prevention and treatment-resistant strategies; child, adolescent, bipolar, and perinatal treatment reviews.
References
- Depression
Agency explanation
NIMH · Content/publication date: 2024
Accessed: 2026-10-06 UTC · Selected official page text; cited sections inspected
Cited sections: Definition; Types; Psychotherapy; Treatment selectionBroad treatment categories only; drug-specific labels are not inferred from this educational overview.
- Depression in adults: treatment and management, NG222 — Recommendations
Clinical guideline
NICE · Content/publication date: not stated
Accessed: 2026-10-06 UTC · Indexed official guideline excerpts; direct full-page access blocked
Cited sections: Recommendations 1.3.3, 1.5.2 and 1.5.3Quoted recommendations are dated 2022 in the retrieved excerpts. Selected recommendations inspected, not the complete evidence review.
- Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis
Published systematic review
Cipriani and colleagues · Content/publication date: 2018
Accessed: 2026-10-06 UTC · Published review abstract only; full text and risk-of-bias tables not appraised
Cited sections: Abstract: eligibility; Findings; InterpretationAcute adult major-depression trials; not a personalized drug ranking. DOI: 10.1016/S0140-6736(17)32802-7. Certainty categories quoted are the review authors’ assessments, not independent atlas grades.
- Antidepressants
Agency explanation
NHS · Content/publication date: 2025-06-12
Accessed: 2026-10-06 UTC · Selected official page text; cited sections inspected
Cited sections: Types; Side effects; Stopping; Follow-up - Brain Stimulation Therapies
Agency explanation
NIMH · Content/publication date: not stated
Accessed: 2026-10-06 UTC · Selected official page text; cited sections inspected
Cited sections: ECT; rTMS; Indications; Risks - Help for Mental Illnesses
Agency explanation
NIMH · Content/publication date: 2026-04
Accessed: 2026-10-06 UTC · Selected official page sections inspected
Cited sections: Where can I get immediate help?US 988/911 services; distinguish from local resources outside the US.
- Depression
Agency explanation
NIMH · Content/publication date: not stated
Accessed: 2026-10-13 UTC · Indexed original agency passages inspected
Cited sections: Original agency explanation: depressive illness and interacting causes - Persistent Depressive Disorder
Agency explanation
NIMH · Content/publication date: not stated
Accessed: 2026-10-13 UTC · Selected original page passages inspected
Cited sections: Definition; impairment distribution (historical survey population)Definitions used; historical prevalence estimates not presented as current.
- Bipolar Disorder
Agency explanation
NIMH · Content/publication date: not stated
Accessed: 2026-10-13 UTC · Selected original page passages inspected
Cited sections: Mood episode types; diagnosis and treatment - Maintenance or Discontinuation of Antidepressants in Primary Care
Randomized trial
Lewis and colleagues; ANTLER investigators · Content/publication date: 2021
Accessed: 2026-10-13 UTC · Original abstract inspected; no independent full-text appraisal
Cited sections: Abstract: enrollment; randomized maintenance/discontinuation; 52-week relapse and withdrawal - Cost and Outcome of Behavioural Activation versus Cognitive Behavioural Therapy for Depression (COBRA): a randomised, controlled, non-inferiority trial
Randomized active-comparator noninferiority trial
Richards and colleagues · Content/publication date: 2016
Accessed: 2026-10-20 UTC · Full original retrieved after native challenge; complete summary and selected procedures/discussion/disclosures read.
Cited sections: Summary; therapy procedures/training/supervision; missing data and applicability; disclosuresNIHR funded; a coauthor disclosed book royalties. Symptom comparison, selected adults and substantial missing outcomes.
- Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trial
Randomized superiority trial; original and fuller study report grouped
Kuyken and colleagues · Content/publication date: 2015
Accessed: 2026-10-20 UTC · Full original publisher PDF read through Oxford author repository: complete summary and selected methods/discussion/disclosures. Original correction independently read; NIHR report abstract read.
Cited sections: Original Summary; eligibility; MBCT support; discussion/limitations; interests; 2016 Department of ErrorNIHR funded; MBCT teaching/company interests disclosed. The 2016 correction documents an unlisted quality-of-life outcome; authors say interpretation unchanged.
Scope & review
- Population
- Primarily adults with unipolar depression; children, bipolar disorder, and perinatal care require distinct assessment
- Exposure or intervention
- Psychological treatments, antidepressants, monitored stopping, and selected brain-stimulation therapies
- Comparison
- Selected care categories explained; no individual treatment ranking
- Outcomes
- Symptoms, functioning, tolerability, and limits of average treatment evidence
- Timeframe
- Source snapshot; no new follow-up analysis
- Jurisdiction
- US NIMH explanations; UK NICE and NHS guidance; international adult trials
Selected-source educational explanation using inspected official source sections and, where stated, an original guideline or published review abstract. This is not a systematic evidence synthesis, independent formal certainty assessment, or qualified expert review.
Sources checked on their individual access dates. Selected sources were checked; ongoing surveillance and qualified review have separate statuses on the coverage page.
Revision history
- 2026-10-06 UTC: New selected-source adult depression explainer with care categories, severity-scoped guidance, original review findings and limits, withdrawal, brain stimulation, and five questions.
- 2026-10-06 UTC: Added related reading and made remaining editorial scope explicit in edition 3.1; source-access dates retained.
- 2026-10-13 UTC: Added concrete categories, scientific uncertainty and selected primary source explanations; preserved existing section, question and source IDs. No independent expert or systematic review completed.
- 2026-10-20 UTC: Added supported foundational, practical and evidence explanations after reading full target bodies and relevant current/pending adjacent coverage. Original sections, questions and sources preserved as exact prefixes; qualified review pending.
What this article still leaves open
- psychotherapy-by-psychotherapy comparisons
- long-term relapse prevention and treatment-resistant strategies
- child, adolescent, bipolar, and perinatal treatment reviews
Suggest a correction
Submit a content correction to the editorial queue, or download a local note. Leave out personal medical details. Submitted text is stored privately with a browser receipt session and is visible to this browser and the editor. Clearing cookies removes access to your submission history. This is not an account or a medical service.
Your submitted corrections for this article
Explore the topic map
Browse the health domains connected to this article. The map also identifies topics whose articles remain unwritten.